CHRYSALIS BIOTHERAPEUTICS

Live / Registered — Registered (as of 19 Aug 2025)

What this means for you

Registered since 19 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90052179
Registration number
7906972
Mark type
Stylized text
Filed
14 Jul 2020
Published for opposition
16 Mar 2021
Registered
19 Aug 2025
Attorney of record
Shannon T. Vale

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and diabetic foot ulcers; Pharmaceuticals for the treatment of acute radiation syndrome; Pharmaceuticals for the treatment of COVID-19; Pharmaceutical products for the prevention and treatment of Degenerative Brain Diseases and Traumatic Brain Injury (TBI)

Owner

Prosecution history

  • 19 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 19 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
  • 31 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 31 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 30 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 30 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 30 Jul 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
  • 07 May 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 07 May 2025 — FINAL REFUSAL E-MAILED
  • 07 May 2025 — SU - FINAL REFUSAL - WRITTEN
  • 17 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 17 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 17 Apr 2025 — ASSIGNED TO LIE
  • 28 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 15 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED

View this trademark record on Marksy